Financial Performance - Revenue for FY2025 reached HK$538,831,000, representing a 52.5% increase from FY2024's revenue of HK$353,651,000[23] - Gross profit for FY2025 was HK$293,342,000, up from HK$202,330,000 in FY2024, indicating a gross profit margin improvement[23] - Operating profit for FY2025 was HK$23,180,000, a significant recovery from an operating loss of HK$97,162,000 in FY2024[23] - The net profit for FY2025 was HK$10,581,000, compared to a net loss of HK$103,615,000 in FY2024, marking a turnaround in profitability[23] - The return on equity (ROE) for FY2025 was 2.2%, recovering from a negative ROE of (23.1%) in FY2024[23] - The basic earnings per share for FY2025 was HK$0.0053, a recovery from a loss per share of HK$0.0518 in FY2024[23] - The Group's net profit for 2025 is approximately HK$10.6 million, a significant recovery from a net loss of approximately HK$103.6 million in 2024[70][74] Revenue Breakdown - The breakdown of turnover by activities shows 66.0% from conventional products, 32.6% from beauty apparatus, and 1.4% from services[26] - The Group's revenue increased by 52.4% to HK$538.8 million in 2025, up from HK$353.7 million in 2024, primarily driven by a HK$180.7 million increase in product sales, which accounted for 98.6% of total revenue[32][35] - Revenue in the PRC market rose by 74.7% to HK$445.8 million in 2025, compared to HK$255.2 million in 2024, largely due to increased sales of beauty apparatus[33][44] - Revenue from the Taiwan market decreased by 2.6% to HK$89.7 million in 2025, down from HK$92.1 million in 2024, attributed to a cautious economic outlook[33][45] - Revenue from other regions, including Hong Kong and Malaysia, fell by 48.4% to HK$3.3 million in 2025, contributing only 0.6% to the Group's total revenue[33][34] Cost and Expenses - The cost of sales for FY2025 was HK$245,489,000, which is an increase from HK$151,321,000 in FY2024, indicating rising costs associated with increased revenue[23] - Total administrative expenses decreased by HK$8.6 million to HK$71.8 million in 2025, with significant components including staff costs of HK$33 million and consultancy fees of HK$10.8 million[52] - Distribution and selling expenses as a percentage of revenue decreased from 48.4% in 2024 to 37.2% in 2025, despite an increase in total distribution and selling expenses to HK$200.3 million[51] Market Performance - Sales of beauty apparatus surged by 504.7% to HK$175.8 million in 2025, compared to HK$29.1 million in 2024, making up 32.6% of total revenue[38][41] - Service income increased by 137.0% to HK$7.7 million in 2025, up from HK$3.3 million in 2024, driven by self-owned spas[40][43] - Total revenue from the PRC market rose by 74.7% to HK$445.8 million in 2025, driven by a 73.4% increase in product sales and a 208.9% increase in service revenue[49] Strategic Initiatives - The Group launched new product lines, including "Crystal Peptide & Health Food" and the INDIBA Moonlight beauty device, enhancing its product portfolio[96] - The Group is leveraging AI technology across the entire supply chain, aiming to build an authoritative AI skin health detection platform trained on millions of samples[115] - The Group implemented a "One Product, One Code" traceability system in collaboration with Fudan University, enhancing transparency and management standards[97] - The Group's strategic partnership with Fudan University aims to establish a transparent management standard through a traceability system[101] Governance and Compliance - The Board of Directors consists of eight members, including three executive directors, two non-executive directors, and three independent non-executive directors[137] - The Company has adopted a code of conduct for securities transactions that meets or exceeds the standards set out in the Model Code, with no reported incidents of non-compliance for the year ended December 31, 2025[153][154] - The Company allows directors to seek independent professional advice at its expense, ensuring informed decision-making[151] - The Company has established guidelines for securities transactions by relevant employees, ensuring adherence to compliance standards[154]
自然美(00157) - 2025 - 年度财报